RCORP - Rural Center of Excellence on SUD Prevention

Search pages...

RCORP - Rural Center of Excellence on SUD Prevention

Search pages...

How Providers and Educators in Appalachian Kentucky Came Together to Deliver Buprenorphine Treatment

Videos
Treatment

Dr. Cheryl McClain, Kentucky state medical director at BrightView Addiction Centers, and David A. Gross, MPA, director of the Northeast Kentucky Area Health Education Center, share how their region came together to respond to the opioid crisis. As the former associate chief medical officer at St. Claire Medical Center, Dr. McClain grew to recognize the urgent need for buprenorphine treatment for people with opioid use disorder (OUD), spearheading a community-based effort that supports patients’ recovery. David A. Gross speaks to the educational efforts that encouraged providers in the region to include buprenorphine treatment programs in their practices.

Transcript

I think anyone living in Appalachian Kentucky has known that the substance

use disorder epidemic has been a problem for a considerable amount of time and back

into the late 1990s really the Oxycontin issue became a big problem in our region.

But it wasn't until about 2016 there was an instance where within a brief

amount of time there were 10 overdoses in Rowan County, Kentucky, which is where

St. Claire Healthcare is based.

During that time there was a stigma for treating these patients if they were ongoing and active IV drug users.

Quite a few of the specialists that would treat hepatitis would not

even consider treating this population mainly because of the cost of the drugs

and the fact that they could then be considered to be re-infected because

they were continuing to use.

So I noticed in this group that they were very discouraged by the amount of

care that they were receiving not only for the hepatitis C but also

for the addiction.

With the stigma surrounding addiction and

the treatment availability, this group was very discouraged.

Some of the younger providers that had just gotten out of residency were

feeling overwhelmed with the amount of polysubstances or multiple controlled

substances that patients were taking and being prescribed. It came to my

attention the number of patients who were not necessarily needing the medications

that were being prescribed were taking them in manners that were not safe

and taking basically too many medications and in fact had an underlying substance use

disorder.

So at that point we began to interview a psychiatrist who was working at

University of Kentucky who had an interest in buprenorphine or the

suboxone type clinics, and she was doing a fellowship in addiction medicine.

So during that time of interview I said would you be interested in starting a

suboxone clinic here or an MAT clinic, an MOUD clinic, here at

St. Claire, and she in fact was very interested, very excited about that.

So during the time that she left UK and came to St. Claire, we put together

policies and protocols and started our own buprenorphine

medication assisted treatment program at

S. Claire, at the St. Claire counseling center. 

So the providers were able then to spend more time during

their patient visits talking to the patients about their actual

health care, about their actual needs for health care, and allowed the providers that were

participating in the MAT, the medication

assisted treatment, to focus on the substance use disorder, in treating that

patient, getting that patient into their recovery, and focusing on the

addiction side of that.

So what we saw was an improvement or an increase in those patients coming to the

program, being involved, decreasing the number of controlled substances that they were on, improving their safety profile and in being much

happier with their quality of life.

Many of these patients lose their children and have lost custody to grandparents or

their cousins even or foster care. We have seen an incredible 25

plus the need in foster care for this group of patients and this population, so

to see them work with the Cabinet for women and children and the drug courts and

their probation officers and get their children back

has been a big part of the joy of being able to deliver

this type of treatment with the medication assisted treatment.

One of the biggest barriers that I have seen with providers wanting to provide

this service is lack of knowledge which creates a disrupt or a discomfort

and also the amount of regulations that a provider has to follow when

prescribing the buprenorphine type products. 

So by developing an educational program where we can relieve some of that angst

or distress or discomfort and teach the providers and show them exactly what

needs to be done was a big part of the program that AHEC has

developed in getting providers more comfortable and willing to get

their X waiver and treat these patients with the buprenorphine type

products.

And we had an incredibly low number of providers that had the waiver in

order to provide, to prescribe a suboxone within the region, a very low number within the 17

county region AHEC serves, so when we started the educational initiatives it

was really topics focused on just what is medication assisted treatment, what is, we had a topic that was called the disease of addiction just to re-emphasize to providers that how big a problem addiction was in the region, that in many cases it had been overprescribing of medications that had led to the issues within our region.

But we found early on that there was a lot of interest in that topic, and we had success early

on in terms of allowing providers within the region to attend a few educational sessions and

then obtain their waiver to prescribe suboxone.

The medical director for the Gateway District health department came

up with the idea for what we're calling an MAT training resource center. So he

said we need to come up with a training that is focused just on those who have

gotten this waiver and aren't utilizing it yet. So with Dr McClain and some of her

partners we put this training resource center together

where we've done an MAT boot camp and other trainings. We have an MAT

mentorship initiative where Dr. McClain works directly with a cohort of

providers that again have gotten the waiver, and we're hopefully transitioning

them toward being able to utilize it. But it is a major undertaking within our

region. It's required a great deal of attention, but it's worth that effort.

Admitting that you have a problem, that something else controls

your life, takes a great deal of courage. So anything that can help someone

face that and admit that and get their life onto the path of recovery

is going to be a tremendous move forward for not only that patient but their

family and their community.

Working and hearing their stories and hearing their cries for help and

answering the questions and being a part of the solution was a big part in

transformation of me going from basically not understanding and not knowledgeable about addiction to becoming an addictionologist.

They come to you needing a tremendous amount of stability

in their life, and the rewarding fact is when they do create that stability and

they get into their recovery and then they're able to get back

into their life they're able to have those relationships that they were destroying prior

when they were using.

They're able to get their job back; they're able to get their children back. And they are

some of the most grateful people that you will find and happy and want to come see you. They want to be at that visit, they want to be a part of what they're doing to get their quality of life back. 

Their stories are incredible and they are so grateful, and that is very rewarding from

a provider's standpoint, seeing that and being a part of that.

Questions? Interested in learning more about increasing access to treatment for OUD and reducing stigma? Contact our Program Assistance.

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2026 University of Rochester Medical Center

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2026 University of Rochester Medical Center

This HRSA RCORP RCOE program is supported by the Health Resources & Services Administration (HRSA) of the US Department of Health & Human Services (HHS) as part of an award of $3.33M in the current year with 0% financed with non-governmental sources.

The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by HRSA, HHS or the US Government.

As the Rural Communities Opioid Response Program (RCORP)-Rural Center of Excellence on SUD Prevention, UR Medicine Recovery Center of Excellence provides access to a wide range of resources on relevant topics. Inclusion in this document does not imply endorsement of, or agreement with, the contents by UR Medicine Recovery Center of Excellence or HRSA.  

© Copyright 2026 University of Rochester Medical Center